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Abstract
A rapid and sensitive immunoassay platform integrating polymerized monoliths and gold
nanoparticles (AuNPs) has been developed. The porous monoliths are photopolymerized in
situ within a silica capillary and serve as solid support for high-mass transport and
high-density capture antibody immobilization to create a shorter diffusion length for
antibody–antigen interactions, resulting in a rapid assay and low reagent consumption. AuNPs
are modified with detection antibodies and are utilized as signals for colorimetric
immunoassays without the need for enzyme, substrate and sophisticated equipment for
quantitative measurements. This platform has been verified by performing a human IgG
sandwich immunoassay with a detection limit of 0.1 ng ml−1. In addition, a single assay can be
completed in 1 h, which is more efficient than traditional immunoassays that require several
hours to complete.
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1. Introduction
Immunoassays such as enzyme-linked immunosorbent assay
(ELISA) and nucleic acid sequence-based amplification
(NASBA) are well-established biomolecular detection
techniques that are used in aid of drug discovery and disease
diagnostics [1–3]. Highly sensitive and selective results
can be obtained from strong noncovalent antibody–antigen
interactions, and the detection signal of low abundant analytes
can be amplified efficiently through the high-turnover
catalysis of the detection substrate by enzymes [4]. However,
the multiple incubation, washing and blocking steps that
take hours to complete would limit the application of the
immunoassays for real-time clinical diagnosis and subsequent
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treatment. In addition, the analyte and reagent consumption
is not only costly, but also presents a challenge for clinical
samples that are available in limited quantities.
Conventional assays are typically carried out in surface-
coated multi-well plates. Because the antibody–antigen
interactions occur in open wells, diffusion limits the
extent to which antigens can interact with the antibodies
that are immobilized on the side of the wells. To
increase the assay efficiency and decrease the analyte and
reagent consumption, high surface-to-volume ratio materials,
such as magnetic microbeads [5–7], polymer microbeads
[8, 9], hydrogels [10, 11] and porous monoliths [12, 13] were
adopted to anchor larger amounts of primary antibodies. They
provide larger surface areas for binding more antibodies per
unit assay volume, and they contribute to a shorter diffusion
distance between adjacent antibodies; therefore, the analysis
time can be decreased from hours to minutes, and higher
detection sensitivity and less reagent consumption can be
achieved.
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Following their successful synthesis and preparation,
nanomaterials such as carbon nanotubes (CNT) [14, 15],
graphene [16, 17], nanowires [18, 19] and nanoparticles
[20, 21] have been widely adopted for multiplex immuno-
assays. Nanomaterials function as higher surface-to-volume
ratio carriers, and their specific physical and chemical
properties increase the versatility of assay platforms such
as field-effect transistors (FETs) for label-free biomolecule
sensing and detection [15, 16, 18]. However, sophisticated
laboratory infrastructure and well-trained operators are
needed for the complicated fabrication processes and
acquisition of assay results.
Among the nanoparticles that are used for biosensing,
gold nanoparticles (AuNPs) are attractive because
of their simple preparation method, high stability,
biocompatibility and distinctive optical and versatile
chemical properties [22–25]. Based on the surface plasmon
resonance (SPR) effect, the color of the 13 nm diameter
monodispersed colloid AuNPs is red and the absorbance
wavelength is centered at approximately 520 nm [25,
26]. Various colorimetric biosensing mechanisms have
been developed utilizing the characteristics of absorbance
wavelength change in an electrolyte solution [27] and the
stronger molar absorptivities than organic dye [28, 29].
However, most of these assays require ∼1 ml volume for a
single assay, and the conjugation of biomolecules to AuNP
surfaces takes hours to complete.
In this report, we propose a colorimetric immunoassay
platform combining photopolymerized monoliths as a high
surface-to-volume ratio solid support for antibody binding and
AuNP immunoprobes for colorimetric detection signaling.
Monoliths are porous structures containing surface groups
that can be easily modified [30], and they have been widely
used as stationary phases for biochemical separation and
analysis [31, 32]. To increase the number of antigen detection
sites, porous monoliths are modified to contain a thiol
ligand on their surfaces, and then they are reacted with
the cysteine sulfhydryl group of capture anti-human IgG
(caHIgG) to form intermolecular disulfide bridges between
antibodies and the side groups on the monoliths [33].
AuNP immunoprobes are prepared using secondary aHIgG
to electrostatically modify the AuNP surfaces [34]. Different
concentrations of analytes, human IgG (HIgG), from
0.1 ng ml−1 to 1 mg ml−1 in phosphate buffered saline (PBS)
buffer, were added to an aHIgG–AuNPs solution to form the
HIgG–aHIgG–AuNPs complexes. After injecting the solution
of HIgG–aHIgG–AuNP complexes into the silica capillary,
the HIgG–aHIgG–AuNPs interacted with and were captured
by the caHIgG-monolith surfaces beginning from the head
of the monolith, resulting in different lengths of monolith
segments that changed color from white to dark red according
to the amount of HIgG–aHIgG–AuNPs that was bound
to the caHIgG monolith. The colorimetric immunosensing
platform permits rapid and low reagent-consuming analysis
with the potential for cost-effective and portable point-of-care
diagnosis applications.
2. Experimental
2.1. Chemicals and reagents
Methanol, ethanol, acetone, acetonitrile, sodium hydroxide,
hydrochloric acid, 3-methacryloyloxypropyl trimethoxy-
silane, glycidyl methacrylate (GMA), ethylene dimeth-
acrylate (EDMA), 2,2-dimethoxy-2-phenylaceto phenone
(DMPA), cysteamine, trisodium citrate, bovine
serum albumin (BSA), PBS, tris-borate-EDTA (TBE), sodium
chloride, TWEEN 20, HIgG, monoclonal anti-HIgG and
anti-HIgG (whole molecule) were purchased from
Sigma-Aldrich (St Louis, MO). Hydrogen tetrach-
loroaurate(III) trihydrate was obtained from Acros (Geel,
Belgium).
2.2. Characterization
The morphology of the monoliths was inspected using a
scanning electron microscope (SEM; JSM-6700F, JEOL,
Tokyo, Japan). The sizes of the synthesized AuNPs were
verified by a transmission electron microscope (TEM; H7100,
Hitachi High-Technologies, Tokyo, Japan). The concentration
of AuNP colloids and the functionalization of aHIgG–AuNPs
were characterized optically by UV–Vis spectroscopy (Cintra
10e, GBC, Victoria, Australia). Immunoassay colorimetric
results were recorded using a desktop scanner (V370,
Seiko Epson Corp., Nagano, Japan) and image analysis was
performed using the free software ImageJ (National Institutes
of Health, US).
2.3. AuNPs preparation
AuNPs with an average diameter of 13 nm were prepared by
citrate reduction of HAuCl4 [38]. A 1 mM HAuCl4 solution
(250 ml) was prepared and stirred while boiling. An amount
of 25 ml 38.8 mM trisodium citrate was added and refluxed for
an additional 15 min. When the color of the solution changed
from yellow to deep red, the solution was cooled to room
temperature. The concentration of AuNP colloids used in all
tests was determined according to the Beer–Lambert law via
absorbance measurement [39].
2.4. Formation of photopolymerized monoliths
First, the fused silica capillary was vinylized for monolith
anchoring [40]. A homogenized and deaerated mixture
consisting of 24 wt % GMA (functional monomer), 16 wt%
EDMA (cross-linker), 30 wt% methanol and 30 wt% ethanol
(porogens) and 1 wt% DMPA (photoinitiator, with respect to
monomers) was then used to fill the vinylized capillary. After
sealing both ends with septa, the silica capillary was exposed
to UV irradiation using a xenon arc lamp at a power density
of 20.0 mW cm−2 for 8 min through a photomask. After the
monoliths were formed, the silica capillary was rinsed with
acetonitrile and nanopure water.
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2.5. Monoliths modified with antibodies
The poly(GMA-co-EDMA) monolith was modified with
caHIgG antibodies through surface thiol-functionalization
and antibody binding processes. A 2.5 M aqueous cysteamine
solution was added to the monoliths with a flow rate of
1µl min−1 for 1 h at room temperature. The monoliths were
then rinsed with nanopure water at a flow rate of 3µl min−1
until the pH of the eluent was neutral.
A 4µg ml−1 monoclonal caHIgG antibody solution was
passed through the monoliths at 5µl min−1 for 10 min and
incubated at room temperature for 10 min. A 5µl min−1 wash
with PBS buffer for 30 min was conducted to remove unbound
antibodies from the monoliths. A blocking buffer containing a
PBS buffer with 1% BSA and 0.1% TWEEN 20 was pumped
into the silica capillary at 5µl min−1 for 30 min and then
incubated for 10 min to eliminate nonspecific binding to the
capillary sidewalls and monolith surfaces. Excess blocking
buffer and unbound BSA were removed by rinsing with the
PBS buffer at 5µl min−1 for 30 min.
2.6. Formation of antibody conjugated AuNP probes
A modified method described by Parolo et al was used
to obtain AuNPs conjugated with aHIgG antibodies [34].
The pH of AuNP colloids (15 nM, 1.5 ml) was adjusted to
7.4 using TBE buffer, followed by the addition of 100µl
antibody solution (2µg ml−1) and a 20 min incubation step.
A 100 µl aqueous solution of 1 mg ml−1 BSA in nanopure
water was added and incubated for 20 min. The solution was
then centrifuged at 14 000 rpm for 20 min. The supernatant
was removed and the AuNP pellets were redispersed twice
in 500µl 2 mM TBE buffer with sucrose (10 wt%).
2.7. Colorimetric immunoassay
To evaluate the performance of the colorimetric immunoassay,
different concentrations of HIgG from 0.1 ng ml−1 to
1 mg ml−1 were prepared in PBS buffer. aHIgG–AuNP (50µl)
was incubated with various concentrations of 50µl HIgG
solution in an Eppendorf tube for 30 min and infused into
the silica capillary at 5µl min−1 for 10 min. After a 10 min
incubation, the excess or unbound HIgG–aHIgG–AuNPs were
removed by rinsing with a PBS wash buffer (0.05% Tween
20 in PBS, pH 7.6) at 10µl min−1 for 10 min. The control
experiment was performed according to the aforementioned
procedures using aHIgG–AuNPs without HIgG incubation as
the analyte.
3. Results and discussion
The strategy of sandwich immunosensing using porous
monoliths and AuNPs probes is illustrated in figure 1.
First, photopolymerized porous monoliths are modified
with caHIgG through intermolecular disulfide bridges or
other thiol linkages. Then, the AuNP immunoprobes are
prepared via electrostatic binding of the secondary aHIgG
to the AuNP surfaces. Following the mixing of the HIgG
molecules and their conjugation with AuNP immunoprobes,
the HIgG–aHIgG–AuNPs mixture is injected into the
silica capillary and bound to caHIgG on the monolith
surfaces beginning from the head of the monolith, which
results in different lengths of the monolith segments that
change color from white to dark red based on the color
of the AuNP immunoprobes and the amount of HIgG
antibodies.
3.1. Formation of photopolymerized monoliths
To avoid extraction processes using centrifugation or magnets
for bead-based immunoassays, the porous monolith was
used as a solid support within the silica capillary. In
this study, the porous monoliths were selected as solid
supports based on their ease of preparation, high surface
area for denser antibodies to be anchored for sensing,
multiplex surface modification to form a variety of functional
groups on the monolith surfaces, high mass transport and
decreased diffusion length requirement for antibody–antigen
interaction to enable rapid assay execution and low reagent
consumption. These specific characteristics make monoliths
strong candidates for solid supports in immunoassays.
The morphology of the macroporous poly(GMA-co-EDMA)
monolith was analyzed by SEM (figure 1(a)). The SEM
image shows that the monoliths possessed homogeneous
morphology and consisted of globule clusters that were
formed by fused ∼1µm diameter globules.
3.2. Monoliths modified with antibodies
The proposed reaction route to modify caHIgG antibodies
on the monolith surfaces is described in figure 2. The
oxirane moieties of poly(GMA-co-EDMA) monoliths are
chemically modified into thiol groups to covalently attach
caHIgG on the surface via the formation of disulfide
bridges [35]. First, cysteamine is used as the nucleophilic
reagent to chemically modify the oxirane ring on the
pre-treated monoliths to thiol terminal groups [36]. The
caHIgG antibodies are then introduced and the thiol groups
on the monolith surface react with the cysteine sulfhydryl
groups of HIgG to form the intermolecular disulfide bridges
or other thiol linkages between the antibodies and the side
groups on the monoliths [33]. To eliminate the nonspecific
binding of monoliths to other species via electrostatic and
hydrophobic interactions, the caHIgG-modified monoliths
were equilibrated with a 1% BSA/PBS buffer solution. BSA,
an inert protein, caps the unreacted thiol groups that are
more susceptible to react with other species. BSA adsorbs
at the nonspecific binding sites of the monolith surfaces
with thiol terminal groups, thus increasing the chance that
the only interactions that occur would be the immobilized
antibody–antigen interactions.
3.3. Formation of antibody conjugated AuNPs probes
Because the sizes and shapes of AuNPs would affect
their optical-physical and chemical properties, the uniform
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Figure 1. The sandwich immunosensing strategy using porous monolith and AuNPs probes. (a) The monoliths are photopolymerized
within silica capillary forming globule clusters with a ∼1µm diameter. (b) The AuNPs that are used in the tests are ∼13 nm in diameter, as
verified via TEM images. (c) (I) The monoliths are first modified with monoclonal caHIgG and the nonspecific binding sites are eliminated
by surface-attached BSA. (II) AuNP colloids are conjugated with aHIgG, followed by (III) incubating with different concentrations of
HIgG. (IV) The HIgG–aHIgG–AuNPs complex is then injected into a silica capillary and (V) bound to caHIgG on the monolith surfaces.
The amount of HIgG can be determined via the color variance of the bound AuNPs (red) label on the monolith (white) using a smart phone
or a desktop scanner.
Figure 2. Immobilization of antibody on the thiolated monolith surface. Cysteamine is introduced to the poly(GMA-co-EDMA) monoliths
containing oxirane moieties to open the oxirane ring and transform it into a thiol group. When the caHIgG is added, the cysteine sulfhydryl
group of the caHIgG antibody can react with the thiol group on the monolith surface to form the intermolecular disulfide bridges between
the antibody and the monolith.
morphology of AuNPs was characterized using TEM images.
The TEM image reveals uniform sized AuNPs with a diameter
of ∼13 nm (figure 1(b)).
A 10:1 molar ratio of aHIgG to AuNPs was selected
based on the previous experimental results published by
Ambrosi et al [37]. Here, we used 1 nM AuNP colloid to
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Figure 3. The visualization of AuNPs conjugated with antibodies
via UV–Vis spectra. (I) The UV–Vis spectra of AuNPs have an
absorbance peak at 520 nm. (II) After adding 50 mM NaCl solution
to the 1 nM AuNPs colloid, the AuNPs aggregated and the
absorbance peak was red-shifted to ∼625 nm. (III) However, when
we modified the aHIgG antibodies on the AuNPs surface with a
ratio of 10:1, the aHIgG created a steric distance, and it possessed
the same surface charges as the adjacent AuNPs to avoid substantial
aggregation.
mix with 10 nM aHIgG antibodies to form the aHIgG–AuNPs
probes. The conjugation was further confirmed by an AuNP
aggregation test (figure 3). When sufficient amounts of
antibodies electrostatically attach on the AuNP surfaces, they
create a steric distance and possess the same surface charges to
avoid considerable aggregation when the electrolyte solution
is added.
3.4. Colorimetric immunoassay characterization
The performance of the proposed immunoassay was evaluated
by the colorimetric studies of the monolith. The color of the
monolith was white before and after caHIgG modification
(figure 4). The color of the 13 nm diameter monodispersed
AuNP colloid absorbs at 520 nm as a result of the SPR effect
and is red in appearance.
Upon chemical modification of the AuNPs with
aHIgG, the aHIgG–AuNP complex’s optical properties were
slightly perturbed with the peak absorption wavelength
of aHIgG–AuNPs at ∼550 nm (figure 3). Different
concentrations of HIgG from 0.1 ng ml−1 to 1 mg ml−1 in
10 mM PBS buffer (pH 7.4) were added to the aHIgG–AuNPs
solution to form the HIgG–aHIgG–AuNP complex. The
HIgG–aHIgG–AuNPs complex was then injected into a silica
capillary and incubated for 10 min. The HIgG within the
HIgG–aHIgG–AuNPs complex then binds to the caHIgG that
is conjugated on the monolith surfaces via antigen–antibody
binding beginning from the edge of the monolith that is
closest to the solution inlet. Because the capacity of the
caHIgG monolith is limited and the nonspecific binding sites
on the monolith surfaces have been capped by BSA, different
length segments of monolith changed in color from white to
dark red based on the amount of HIgG–aHIgG–AuNP that
was bound to the caHIgG monolith. After rinsing with PBS
Figure 4. Porous monolith-based colorimetric immunoassay
combining AuNPs probes for the detection of HIgG. (a) (I) The
caHIgG-conjugated poly(GMA-co-EDMA) monolith is white. (II),
(III) When 0.1 and 1 nM HIgG–aHIgG–AuNPs mixtures are
injected and captured by the caHIgG-monolith surfaces, the length
of the monolith segments is increased and their color changes from
white to dark red. The higher concentration of HIgG leads to longer
segments of monoliths that turn red. (b) A detection limit of
∼0.1 ng ml−1 is obtained using this immunoassay platform. The
error bars represent the standard deviation from the measurements
(n = 5). A linear correlation existed over the range of
0.1 ng ml−1–10µg ml−1 (R2 = 0.98).
buffer to elute the residual aHIgG–AuNP, the lengths of the
monolith segments with changed colors were recorded by a
desktop scanner.
Figure 4 shows a plot of the length of the monolith with
changed color based on the immunoassay versus the different
concentrations of HIgG. The variance index of the assay is
defined as
I = (L i − L0)/L0,
where the L i and L0 are the mean colored length of the
different concentrations of the injected HIgG–aHIgG–AuNPs
complex and blank tests, respectively. This colorimetric
immunoassay platform has a detection limit of 0.1 ng ml−1
with a turnaround time of 1 h. The limit of detection is defined
as the concentration of a HIgG–aHIgG–AuNPs complex that
produces a signal that is three times higher than the baseline
noise of the control. A broad range of linear correlation exists
over five orders of magnitude, from 0.1 ng ml−1 to 10µg ml−1
(R2 = 0.98). The high sensitivity and large linear dynamic
range mean the assay has potential for diagnostic applications
that are affordable, sensitive, specific, user-friendly, rapid and
robust, equipment-free and deliverable to end-users (assured).
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4. Conclusions
A new type of colorimetric immunoassay platform with
improved temporal acquisition times and sensitivity has been
demonstrated. We have proven that the color contrast that is
created by this method can be utilized as a sensing indicator
for immunoassays. Upon the formation of a monolith–AuNP
complex that occurs through antigen–antibody interactions,
the monoliths turned dark red. Furthermore, enzymes and
substrates that are used for signaling via enzymatic reaction
are not required. The detection limit of HIgG for this platform
is 0.1 ng ml−1 with a linear correlation over a range of
0.1 ng ml−1–10µg ml−1. Additionally, the monoliths provide
a shorter diffusion length between the antibodies and the
mobile analytes, which improves binding efficiency and
results in decreases in the incubation times that are required
for antibody–antigen binding. The turnaround time of the
present platform is 1 h, which is considerably more efficient
than typical sandwich assays that require 6 h. Because the
signal output is colorimetric, the assay can be performed with
a desktop scanner, a smart phone or by visual inspection,
thus eliminating the need for sophisticated optical equipment
that is used in most conventional methods. Other colorimetric
mechanisms using AuNPs for detection, such as disease
diagnosis, therapy and environmental monitoring, can also be
used with this platform. The colorimetric assay mechanism
can also be integrated with a microfluidic platform to provide
efficient and multiplexed flow control coupled with a high
sensitivity, high throughput and low sample consumption
point-of-care diagnostic system.
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